These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8784121)

  • 1. Considerations in the design of clinical trials of neuroprotective therapy in acute stroke.
    Dorman PJ; Sandercock PA
    Stroke; 1996 Sep; 27(9):1507-15. PubMed ID: 8784121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection as initial therapy in acute stroke. Third Report of an Ad Hoc Consensus Group Meeting. The European Ad Hoc Consensus Group.
    Cerebrovasc Dis; 1998; 8(1):59-72. PubMed ID: 9645985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of earlier clinical studies on neuroprotective agents and current approaches.
    Wahlgren NG
    Int Rev Neurobiol; 1997; 40():337-63. PubMed ID: 8989628
    [No Abstract]   [Full Text] [Related]  

  • 4. Does neuroprotection improve stroke outcome?
    Lees KR
    Lancet; 1998 May; 351(9114):1447-8. PubMed ID: 9605797
    [No Abstract]   [Full Text] [Related]  

  • 5. What questions can large, simple trials answer?
    Sandercock P
    Cerebrovasc Dis; 1998 Mar; 8 Suppl 2():30-6. PubMed ID: 9570024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using pathophysiology in acute stroke trials.
    Baird AE; Warach S
    Stroke; 1999 Jun; 30(6):1293. PubMed ID: 10356119
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroprotective therapy in acute ischemic stroke.
    Thurston SE
    Va Med Q; 1998; 125(2):131-2. PubMed ID: 9577717
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroprotection for acute stroke: making clinical trials work.
    Muir KW; Grosset DG
    Stroke; 1999 Jan; 30(1):180-2. PubMed ID: 9880407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of stroke pathophysiology and neuroprotective clinical trial design.
    Muir KW
    Stroke; 2002 Jun; 33(6):1545-50. PubMed ID: 12052989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective and thrombolytic agents: advances in stroke treatment.
    Hock N
    J Neurosci Nurs; 1998 Jun; 30(3):175-84. PubMed ID: 9689609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic therapy in ischemic cerebrovascular accidents].
    Hommel M; Kumral E; Bogousslavsky J
    Praxis (Bern 1994); 1995 Sep; 84(38):1025-31. PubMed ID: 7481300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders.
    Di Mascio R; Marchioli R; Tognoni G
    Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy.
    Weir CJ; Kaste M; Lees KR;
    Stroke; 2004 Sep; 35(9):2111-6. PubMed ID: 15243146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection is unlikely to be effective in humans using current trial designs: an opposing view.
    Lees KR
    Stroke; 2002 Jan; 33(1):308-9. PubMed ID: 11779930
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.
    Fisher M;
    Stroke; 2003 Jun; 34(6):1539-46. PubMed ID: 12750546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reasons why stroke trials underestimate the neuroprotective effects of drugs.
    Spedding M
    Stroke; 2002 Jan; 33(1):324-5. PubMed ID: 11779937
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroprotective therapy for acute ischaemic stroke: down, but not out.
    Goldstein LB
    Lancet; 2004 Feb; 363(9407):414-5. PubMed ID: 14962518
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroprotective therapies in stroke.
    Zivin JA
    Drugs; 1997; 54 Suppl 3():83-8; discussion 88-9. PubMed ID: 9360855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.